Minimizing non-enrolling clinical trial sites

Non-enrolling sites represent a significant loss of time and resources and can jeopardize the overall success of a clinical trial. As clinical trials become more complex and competitive, minimizing the proportion of non-enrolling sites is essential to maximizing the value of clinical trial data while controlling costs.

The PPD™ clinical research business of Thermo Fisher Scientific addresses this challenge through targeted site engagement, rigorous CRA training, data-driven tools, and dedicated patient recruitment and engagement leads (PRELs) who drive proactive, specialized recruitment strategies. This comprehensive, recruitment-focused model helps ensure that sites move from activation to enrollment, supporting more efficient studies that benefit patients, empower sites and deliver stronger outcomes for sponsors.

Explore strategies that minimize non-enrolling sites and enhance study success by downloading the full white paper.